Thynk Capital Fund Manager Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Type

Private Equity Firm

Location

Las Vegas NV US

Alternative Asset Classes

Established

2003

Firm Ownership

Independent Firm

Investment Team Staff

Total Staff

Thynk Capital is a US-based venture capital firm that focuses on investing in early-stage pharma and biotech companies. More specifically, the firm focuses on major diseases of aging including Alzheimer's, dementia, kidney disease, cancer, cardiovascular, diabetes, frailty, and rare disease.

Asset Class	No. of Funds Currently Managed	Strategies
Private Equity	2	Early Stage, Early Stage: Seed, Early Stage: Start-up, Recapitalisation
Real Estate	-	-
Private Debt	-	-
Infrastructure	-	-
Natural Resources	-	-

Asset Class	No. of Funds Currently Managed	AuM	Date of AuM	Strategies
Hedge Funds	0			-

Want to see more?

Request a demo for full access to this profile.

1 Known Decision Makers

Contact Name	Position	Location	Email	Telephone	Asset Class
	Founder	Las Vegas, US			PE VC

Showing 1 of 1 known decision makers at Thynk Capital

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

2 Private Capital Funds Managed

Fund Name	Vintage	Strategy	Status	Fund Structure	Closed Size (MN)	Target Size (MN)	Primary Region Focus
		Venture (General)	Closed	Commingled			North America
		Venture (General)	Closed	Commingled			North America

Showing 2 of 2 private capital fund managed by Thynk Capital